Senior Vice President Marketing
NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's nCounter Analysis System has been employed in life sciences research since it was first introduced in 2008 and has been cited in more than 800 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company's technology has also been applied to diagnostic use. The Prosigna Breast Cancer Prognostic Gene Signature Assay together with the nCounter Dx Analysis System is FDA 510(k) cleared for use as a prognostic indicator for distant recurrence of breast cancer.
Results-driven business leader with over 20 years’ experience in biotech strategy development, product management, marketing and channel management. Thrives in fast-paced emerging markets with experience establishing scalable infrastructure to support growth. Proven success in the development and implementation of commercialization strategies for both large capital equipment and renewable consumable businesses. Outstanding leadership and performance record recognized for successfully leading teams through periods of significant change while inspiring them to achieve high productivity and innovation. Articulate and passionate spokesperson for the advancement of genomics and precision medicine.
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you’re looking to find the email of Anna Berdine at Nanostring Technologies then you’ve come to the right place.
Wondering if it's anna@nanostring.com, anna.berdine@nanostring.com, berdine@nanostring.com, or aberdine@nanostring.com? We have the answers for you.